Sub-clinical stimulation for Parkinson's Disease

Standord University Medical Center, Stanford, CA
Parkinson's Disease+1 More ConditionsSub-clinical stimulation - Device
Eligibility
21 - 80
All Sexes

Study Summary

This trialwill study Parkinson's disease and sleep dysfunction, exploring ways to manipulate brain signals to improve sleep. #PD #Parkinsons #Sleep #DBS #DeepBrainStimulation

Eligible Conditions
  • Parkinson's Disease
  • Sleep Fragmentation

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Years 1-2

Years 1-2
Sleep Quality
Sleep stage duration and transitions

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

PD with DBS
1 of 1

Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Sub-clinical stimulation · No Placebo Group · N/A

PD with DBS
Device
Experimental Group · 1 Intervention: Sub-clinical stimulation · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: years 1-2

Who is running the clinical trial?

University of PennsylvaniaOTHER
1,899 Previous Clinical Trials
41,218,043 Total Patients Enrolled
University of NebraskaLead Sponsor
497 Previous Clinical Trials
1,150,697 Total Patients Enrolled
Stanford UniversityOTHER
2,222 Previous Clinical Trials
34,904,077 Total Patients Enrolled
University of Colorado, DenverOTHER
1,644 Previous Clinical Trials
1,661,021 Total Patients Enrolled
John Thompson, PhDPrincipal InvestigatorUniversity of Colorado, Denver
1 Previous Clinical Trials
336 Total Patients Enrolled
Aviva Abosch, MD, PhD2.76 ReviewsStudy Director - University of Nebraska
University of Nebraska
3 Previous Clinical Trials
91 Total Patients Enrolled
5Patient Review
I had a lobectomy done in April 17, 2014. I was in great care by Dr. Abosch and staff for the 21 days I was in the hospital. Everything leading up to my surgery was explained to me thoroughly so that I understood what all was being done. I will never forget how well not only myself was cared for but also my husband for being there with me. I often wonder to this day what Dr. Abosch and her team has learned from my right temporal lobe by chopping it up. I still think it would of made a cool night light or just give someone a piece of my mind. To this
Casey Halpern, MDPrincipal InvestigatorStanford University
Clete Kushida, MD, PhDPrincipal InvestigatorStanford University

Eligibility Criteria

Age 21 - 80 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Your motor symptoms are so severe that even with the best available medication, you need surgery to implant a device called DBS.
You have been diagnosed with Parkinson's disease for at least four years and have motor symptoms.
You have tried oral medication for Parkinson's disease but it did not provide enough relief for your movement symptoms.

Frequently Asked Questions

Is senior participation being allowed in this clinical experiment?

"This clinical trial has a strict age range that applicants must adhere to, which is 21-80 years old. Meanwhile, separate trials exist for those under the age of 18 (31) and over 65 years old (496)." - Anonymous Online Contributor

Unverified Answer

How many participants can the trial feasibly accommodate?

"Affirmative. According to clinicaltrials.gov, this research investigation was first posted on October 21st 2020 and is actively recruiting participants. Currently, the trial needs 20 volunteers from two medical centres for its data collection efforts." - Anonymous Online Contributor

Unverified Answer

Is eligibility open to join this medical experiment?

"This trial is recruiting 20 participants with Parkinson's Disease, aged between 21 and 80. If you meet these criteria, then you are qualified to join the clinical study." - Anonymous Online Contributor

Unverified Answer

Is the opportunity to participate in this experiment available at present?

"Clinicaltrials.gov reveals that this trial is actively seeking participants as of today's date; the initial post was published on October 21st, 2020 and has been recently modified on November 4th, 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.